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OVER a period of 15 years, we have investigated (at the request of the chro-
mates-producing industry in Great Britain) the carcinogenicity ofseveral different
chromium-containing compounds by the technique of single or repeated intra-
muscular injection in rats and/or mice. The results ofthese tests were invariably
negative until, at the independent suggestions of Dr. Sidney Laskin and Dr.
Lesley Bidstrup, calcium chromate was examined in the same way.
The results of this experiment are now reported. Although a strikingly high
yield of tumours was obtained, the present findings do no more than confirm
those of Hueper and Payne (1959). But independent corroboration of their
assertions in respect of calcium chromate seemed especially necessary in view of
our inability to induce injection-site tumours with chromite ore roast, chromite
roast residues or chromic chromate-all of which Hueper and Payne reported as
carcinogenic on intramuscular (and also intrapleural) injection in rats (Hueper,
1958; Hueper and Payne, 1959).
The evidence for an association between exposure to chromates and lung
cancer in man, critically reviewed by Gruschko (1961), provides the rationale for
examining chromium-containing compounds for carcinogenicity. If certain
industrial processes could be pin-pointed as especially hazardous, it would be
possible to direct protective meas-ares, currently being taken in all sectors, to
those parts ofthe process which appear to be more likely to be associated with the
risk of lung cancer. This might have the advantage to the industry of reducing
the cost of ensuring that the risk is eliminated. Calcium chromate is formed in
varying amounts when chromite ore is heated with limestone and sodium or
potassium carbonate-the first step in processing the crude ore-and this would
appear to be one important stagewherepotentialcarcinogensmightbeencountered.
The present findings should be considered alongisde those of Laskin and his
colleagues who, at the meeting of the American Industrial Health Association in
St. Louis in May 1968, reported the induction ofsquamous carcinomas ofthe lung
in 6, and adenocarcinomas of the lung in 2, out of 100 rats exposed to calcium
chromate in the form of a pellet attached to the bronchial mucosa.
MATERIALS AND METHODS
Experimental animals.-Forty male CB stock rats, aged 5 to 6 weeks at the
beginning ofthe experiment, were used. They werekept in metal cages, 5 in each,
and fed on cubed diet No. 86 (Messrs Dixon Ltd., Ware, Herts) and water ad
libitum.CHROMIUM CARCINOGENESIS
Calcium chromate.-Calcium chromate was obtained from British Drug
Houses, Ltd.
Conduct of experiment
The rats were divided into a test group of 24 animals and a control group of
16 animals. The test group received 20 once-weekly injections ofcalcium chromate
suspended in 0-2 ml. arachis oil, given intramuscularly into the right flank.
For the first 2 injections, the dose of calcium chromate was 5 mg. but signs of
severe inflammation developed at the site of injection and the dose was reduced
to 0 5 mg. for the remaining 18 weeks. The test animals thus received 19 mg.
calcium chromate over a span of 20 weeks. The control group received 20 once-
weekly injections of 0-2 ml. arachis oil, given intramuscularly into the right flank.
The rats were observed daily and examined for changes at the injection site.
Animals were killed when they developed tumours or at the termination of the
experiment at 63 weeks. Full post mortem examinations were carried out and
tumours and tissues showing macroscopic abnormalities were removed and fixed
in Bouin's solution. Paraffin sections were prepared at 5 ,t and stained with
haematoxylin and eosin.
RESULTS
The results are shown in Table I. No systemic toxic effects attributable to
calcium chromate were observed. During the period when injections were given,
the injection sites became swollen and appeared tender but no ulceration of the
overlying skin developed. The local swelling later subsided but there remained
slight palpable thickening of the subcutaneous tissues at the injection site.
Tumours developed at the injection site in 18 of the 24 test animals (75%/)-
Table I. The first lesion appeared 203 days after the beginning ofthe experiment
TABLE I.-Carcinogenesis in Rats Injected Subcutaneously with Calcium Chromate
Days after the beginning of experiment
150 200 250 300 350 400 440
Test group
Survivors . . . 24 24 24 22 17 9 0
Cumulative total of tumour-bearing rats . . 0 0 3 6 11 16 18
Spindle cell sarcomas . . . 0 0 2 4 8 11 11
Pleomorphic sarcomas . . . 0 0 1 2 3 5 7
Control group
Survivors . . . 15 14 13 12 12 9 0
Total of tumour-bearing rats . . 0 0 0 0 0 0 0
and the overall mean period of induction was 323 days. Once palpable, the
tumours grew rapidly; all tumour-bearing rats were killed before their lesions
began to ulcerate and the interval between the first detection of a tumour and the
time when the rat had to be killed was, on average, 29 days. The neoplasms
induced by calcium chromate were either spindle cell or pleomorphic cell sarcomata
(Fig. 1 and 2). Some of the spindle cell lesions showed quite marked collagen
formation. The pleomorphic tumours contained virtually no collagen fibres and
were composed of bizarre binucleate and multinucleate cells, many of them with
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abnormal mitotic figures. No deposits of chromate were observed in or around
thetumours. Thesarcomas showedwidelocalinvasionofthesubcutaneoustissues,
with extension into the muscles ofthe body wall, but no metastatic deposits were
found.
The injection sites in the 6 test rats which did not develop local tumours, and
in the 16 control animals injected with arachis oil alone, showed no specific
features. There was no epidermal ulceration. The dermis contained increased
amounts of fibrous tissue, infiltrates of macrophages and chronic inflammatory
cells, and dilated lymphatic vessels. These changes were more prominent in
rats injected with calcium chromate than in rats which were given arachis oil only.
No distant tumours developed in any rats in the test or control groups. Some
animals from both groups showed bronchiectasis and cystic nephritis (sometimes
accompanied by hydronephrosis) but there was no difference in the incidence,
extent, or severity of these lesions between the test and control groups.
DISCUSSION
In 1827, Cumin described ulcers and sloughs " of a peculiarly penetrating
character " on the hands and forearms of Scottish workers who handled " bi-
chromate of potass ". Similar cutaneous lesions were observed by later writers
and perforating septal ulcers of the nose were reported in chromate workers by
Delpech and Hillairet in 1869 (see Gafafer, 1952). Neither of these lesions was
pre-neoplastic, no damage to other tissues following exposure to chromium-
containing compounds was noted, and it was not until the 1930's that an associa-
tion between exposure to chromates and the development of malignant disease-
lung cancer-was suspected. German investigators (see reviews by Machle and
Gregorius, 1948; Baetjer, 1950; Gafafer, 1952) were the first to recognise this
association but their data were inadequate to calculate the risk involved; further-
more, the diagnosis of lung cancer was not always firmly established and some
patients had been exposed to other known carcinogens. Machle and Gregorius
(1948) conducted a survey of chromate workers in the United States and reported
an exceptionally high risk of lung cancer in men engaged in the production of
chromates and, to a lesser extent, of chrome pigments. No increase in cancer
of other sites was found. Despite certain criticisms of the design of Machle and
Gregorius's study, Baetjer (1950) confirmed their final conclusion and showed that
lung cancer was not only more common but also occurred earlier in the chromate
workers, the highest incidence being found in the 40-49 age group. In the United
Kingdom, Bidstrup and Case (1956) also reported an increased incidence of mor-
tality for cancer of the lung in the chromate-producing industry and noted a
tendency for death due to bronchogenic carcinoma to occur disproportionately
early. Important non-occupational factors such as the smoking habits and social
class of the workers, and diagnostic bias, were examined and considered to be
EXPLANATION OF PLATE
FIG. 1.-Spindle cell sarcoma arising at injection site of rat treated with calcium chromate.
Tumour palpable at 273 days; rat killed at 300 days. H. and E. x 230.
FIG. 2.-Anaplastic sarcoma arising at injection site of rat treated with calcium chromate.
Tumour palpable at 314 days; rat killed at 339 days. H. and E. x 180.
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inadequate to account for the increased incidence oflung cancer. There is, there-
fore, abundant evidence that bronchogenic carcinoma is an occupational hazard
in the chromate-producing industry.
Until recently, animal experiments have failed to provide a clear indication of
the identity of the compound or compounds which increase the risk of cancer
development in chromate workers. Hueper (1955) reported essentially negative
results in a series of investigations in which various species were exposed to
powdered chromium ore or to pure powdered metallic chromium, administered by
various routes. In 1958, Hueper reported a small number of malignant tumours
developing in rats after intramuscular or intrapleural administration of chromite
ore roast. He stressed that the yield of neoplasms was small and that chromite
ore contained otherputative carcinogens aswell as chromium; but in an addendum
to this paper, he noted that calcium chromate implanted intramuscularly in rats
produced local sarcomas. This observation was extended in a later paper (Hueper
and Payne, 1959), in which it was shown that intramuscular implantation of
calcium chromate or chromium trioxide in rats was followed by local tumours in
60-79% of animals. Calcium chromate was subsequently found to induce in-
jection-site sarcomas in mice (Payne, 1960) but attempts to produce pulmonary
tumours in rats by intratracheal administration of calcium chromate were un-
successful (Hueper and Payne, 1962).
The present findings constitute a complete and independent confirmation of
those of Hueper and Payne (1959) in respect of the potent carcinogenicity of
calcium chromate for the subcutaneous tissues of the rat. As such, they may
serve as a pointer to those concerned with the lung cancer hazard in the chromate-
producing industry. The induction of pulmonary cancers in rats by the intra-
bronchial implantation ofpellets containing calcium chromate or chromic chromate
by Laskin and his colleagues (see introduction) may serve the same purpose.
SUMMARY
Twenty-four young male CB stock rats received 20 once-weekly injections of
calcium chromate, suspended in 0-2 ml. arachis oil, given intramuscularly into the
right flank; each rat received 19 mg. calcium chromate. Sixteen similar control
rats received 20 once-weekly intramuscular injections of 0-2 ml. arachis oil alone.
The experiment was terminated after 63 weeks when the surviving animals were
killed.
Spindle cell and pleomorphic cell sarcomas developed at the site ofinjection in
18 of the 24 test rats (75%/). The first tumour appeared 203 days after the
beginning of the experiment and the mean period of induction was 323 days.
The tumours were locally invasive but did not metastasise. No neoplasms were
found at other sites and no injection-site tumours developed in control rats which
received arachis oil alone.
These observations confirm the previous account by Hueper and Payne (1959)
and indicate that calcium chromate is a potent carcinogen for the subcutaneous
tissues of the rat. The present findings, particularly when taken in conjunction
with the recent report by Laskin and his colleagues oflung cancers induced in rats
with intrabronchial pellets of calcium chromate, indicate that this compound
may be at least one of the carcinogens responsible for the well-documented
cancer-hazard associated with the chromate-producing industry.
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